Table 3.

Societal costs of infections caused by antibiotic resistant bacteria in the EU, Norway and Iceland 2007 (million €)

Bacteria	Hospital costs	Out-patient costs	Productivity losses (absence from work)	Productivity losses (deaths)	Total
MRSA and VRE	424.7	5.5	91.1	145.6	666.9
3rd-generation cephalosporin-resistant Escherichia coli and 3rd-generation cephalosporin-resistant Klebsiella pneumoniae and carbapenem-resistant Pseudomonas aeruginosa	503.1	4.5	59.3	300.3	867.2

Source: EARSS (cf. reference 4).